Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome

Transplantation

Volumn 61, Issue 9, 1996, Pages 1323-1330

  Troppmann, Christoph ^a   Gruessner, Angelika C ^a   Papalois, Basil E ^a   Sutherland, David E R ^a   Matas, Arthur J ^a   Benedetti, Enrico ^a   Gruessner, Rainer W G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL FUNCTION; ENDOCRINE FUNCTION; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; PANCREAS TRANSPLANTATION; TIME FACTORS;

EID: 0029876841     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00007     Document Type: Article

References (39)

1. Tamsma JT, Schaapherder AFM, van Bronswijk H, et al. Islet cell hormone release immediately after human pancreatic transplantation. Transplantation 1993; 56: 1119.
2. Hopt UT, Buesing M, Schareck WD, Becker HD. The bladder drainage technique in pancreas transplantation - the Tuebingen experience. Diabetologia 1991; 34: S24.
3. Schmid T, Koenigsrainer A, Steiner E, Koller J, Margreiter R. Do donor age and cold-ischemia time have a detrimental effect on early pancreas-allograft function? Diabetes 1989; 38: 4.
4. Troppmann C, Benedetti E, Gruessner AC, et al. Vascular graft thrombosis after pancreas transplantation: uni- and multivariate surgical and nonsurgical risk factor analysis. J Am Coll Surg (in press).
5. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938.
6. Wilczek H, Gunnarsson R, Felig P, Ostman J, Groth CG, Wahren J. Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for type I (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 345.
7. Elahi D, McAloon-Dyke M, Clark BA, et al. Sequential evaluation of islet cell responses to glucose in the transplanted pancreas in humans. Am J Surg 1993; 165: 15.
8. Matthews DR, Lang DA, Burnett MA, Turner RC. Control of pulsatile insulin secretion in man. Diabetologia 1983; 24: 231.
9. Braga M, Castoldi R, Cristallo M, Valeri R, Pozza G, DiCarlo V. Catabolic response and parenteral nutrition after simultaneous kidney-pancreas transplantation. Nutrition 1992; 8: 232.
10. Jindal RM. Posttransplant diabetes mellitus - a review. Transplantation 1994; 58: 1289.
11. Johnston C, Raghu P, McCulloch DK, et al. β-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes 1987; 36: 829.
12. Piatti PM, Traeger J, Dubernard JM, et al. Hormonal evaluation of immediate pancreatic function in simultaneous kidney plus pancreas transplantation during artificial pancreas monitoring. Transplant Proc 1985; 17: 346.
13. Korsgren O, Jansson L, Andersson A. Effects of hyperglycemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 1989; 38: 510.
14. Christiansen E, Andersen HB, Rasmussen K, et al. Pancreatic β-cell function and glucose metabolism in human segmental pancreas and kidney transplantation. Am J Physiol 1993; 264: E441.
15. Christiansen E, Tibell A, Groth CG, et al. Limitations in the use of insulin or C-peptide alone in the assessment of β-cell function in pancreas transplant recipients. Transplant Proc 1994; 26: 467.
16. Blackman JD, Polonsky KS, Jaspan JB, Sturis J, Van Cauter E, Thistlethwaite JR. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 12 years after kidney-pancreas transplantation. Diabetes 1992; 41: 1346.
17. Najarian JS, Gillingham KJ, Sutherland DER, Reinsmoen NL, Payne WD, Matas AJ. The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 1994; 57: 812.
18. Gruessner RWG, Troppmann C, Barrou B, et al. Assessment of donor and recipient risk factors on pancreas transplant outcome. Transplant Proc 1994; 26: 437.
19. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation - a multivariate analysis. Transplantation 1995; 59: 962.
20. Lopéz-Medrano RM, Ponce J, Varela G, Chavira SC, Orozco C, Odor-Morales A. Extensive decrease in insulin secretion by the pancreas preserved for 24 hours in UW-1 solution. Transplant Proc 1991; 23: 1676.
21. Morel P, Moudry-Munns K, Najarian JS, Gruessner R, Dunn DL, Sutherland DER. Influence of preservation time on outcome and metabolic function of bladder-drained pancreas transplants. Transplantation 1990; 49: 294.
22. Kubo S, Yamamoto K, Magata Y, et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med 1991; 5: 133.
23. Sutherland DER, Moudry-Munns K, Gruessner A. Pancreas preservation. In: Collins G, Dubernard JM, Land W, Persijn G, eds. Procurement and preservation of vascularized organs. Dordrecht, the Netherlands: Kluwer Academic Publishers, in press.
24. Holley JL, Shapiro R, Lopatin WB, Tzakis A, Hakala TR, Starzl TE. Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990; 49: 387.
25. Troppmann C, Caplan A, Matas AJ, Najarian JS. "Equitable access" or "maximize results" - an ethical conflict in cadaver kidney allocation illustrated by results in patients >90 kg. Abstract presented at the 10th annual scientific meeting of the American Society of Transplant Physicians, Chicago, IL, 1991.
26. Gruessner RWG, Dunn DL, Gruessner AC, Matas AJ, Najarian JS, Sutherland DER. Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 1994; 57: 1598.
27. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984; 38: 643.
28. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
29. Leprini A, Valente U, Barocci S, et al. Expression of HLA-class I molecules in human pancreas. Clin Transplant 1990; 4: 159.
30. Gruessner RWG, Sutherland DER. Clinical diagnosis of pancreas allograft rejection. In: Solez K, Racusen LC, Billingham M, eds. Pathology and rejection diagnosis in solid organ transplantation. New York: Marcel Dekker, 1996: 455.
31. Gruessner R, Najarian JS, Gruessner A, Sutherland DER. Comparison of rejection in clinical transplantation of pancreas alone or associated with kidney transplant. In: JL Touraine, et al., eds. Transplantation and clinical immunology: multiple transplants. Amsterdam: Excerpta Medica, 1991; 23: 47.
32. Gruessner RWG, Nakhleh R, Tzardis P, et al. Rejection in single versus combined pancreas and kidney transplantation in pigs. Transplantation 1993; 56: 1053.
33. Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Ferguson RM. The frequency of rejection episodes after combined kidney-pancreas transplant - the impact on graft survival. Transplantation 1994; 58: 424.
34. Gruessner RWG, Nakhleh R, Tzardis P, et al. Differences in rejection grading after simultaneous pancreas and kidney transplantation in pigs. Transplantation 1994; 57: 1021.
35. Benedetti E, Najarian JS, Gruessner AC, et al. Correlation between cystoscopic biopsy results and hypoamylasuria in bladder-drained pancreas transplants. Surgery 1995; 118: 864.
36. Cook DL, Taborsky GJ. β-Cell function and insulin secretion. In: Rifkin H, Porte D, eds. Diabetes mellitus. Theory and practice. New York: Elsevier, 1990: 89.
37. Frei U, Margreiter R, Harms A, et al. Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients. Transplant Proc 1987; 19: 3539.
38. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant Superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
39. Ismail T, Ayres R., Kiff P, McMaster P, Neuberger J. Enisoprost in liver transplantation. Transplantation 1995; 59: 1298.